RXRX: Recursion Pharmaceuticals Inc - Class A Company Profile & Statistics

About

Recursion Pharmaceuticals Inc. is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering. Recursion Pharmaceuticals Inc. is based in SALT LAKE CITY.

Info & Links

CEO

Christopher Gibson

Headquarters

41S RIO GRANDE STREET
SALT LAKE CITY, UT 84101, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

500

Recursion Pharmaceuticals Inc - Class A Statistics

Valuation Measures

Market Capitalization²

2.17B

Enterprise Value

1.77B

Enterprise Value/EBITDA(ttm)

-4.88

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

41.24

Price to Book(mrq)

3.75

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

29.55%

Operating Margin(ttm)

-579.52%

Profit Margin(ttm)

-640.08%

Return on Equity(ttm)

-76.56%

Return on Invested Capital(ttm)

-76.38%

Return on Assets(ttm)

-55.68%

Income Statement

Revenue(ttm)

65.18M

Revenue Per Share(ttm)

0.23

Gross Profit(ttm)

22.86M

EBITDA(ttm)³

-363.07M

Net Income Available to Common(ttm)

-377.75M

Diluted EPS(ttm)

-1.53

Share Statistics

Beta (5Y Monthly)

0.85

52-Week Change

-11.88%

S&P 500 52-Week Change

25.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

286.64M

Dividend Yield

0.00%

Float⁴

329.18M

% Held by Insiders

15.75%

% Held by Institutions

89.06%

Balance Sheet

Total Cash(mrq)

429.20M

Total Cash Per Share(mrq)

1.50

Total Debt(mrq)

28.73M

Total Debt/Equity(mrq)

5.48%

Current Ratio(mrq)

4.35%

Quick Ratio(mrq)

4.35%

Book Value Per Share(mrq)

1.83

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.86

Free Cash Flow(ytd)

-256.14M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

RXRX

Recursion Pharmaceuticals Inc - Class A

Recursion Pharmaceuticals Inc - Class A Profile